PharmaEngine (ROCO:4162) Cash From Discontinued Investing Activities : NT$0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is PharmaEngine Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

PharmaEngine's cash from discontinued investing activities for the three months ended in Sep. 2024 was NT$0.0 Mil. It means PharmaEngine received NT$0.0 Mil from discontinued investing activities. PharmaEngine's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Sep. 2024 was NT$0.0 Mil.

PharmaEngine Cash From Discontinued Investing Activities Historical Data

The historical data trend for PharmaEngine's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaEngine Cash From Discontinued Investing Activities Chart

PharmaEngine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash From Discontinued Investing Activities

Get a 7-Day Free Trial

PharmaEngine Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash From Discontinued Investing Activities	Get a 7-Day Free Trial															-	-	-	-	-

PharmaEngine Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

PharmaEngine Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of PharmaEngine's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaEngine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaEngine Inc (ROCO:4162) » Definitions » Cash From Discontinued Investing Activities

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Minsheng East Road, 11th Floor, Section 3, Taipei, TWN, 104

Website

https://www.pharmaengine.com

PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its projects pipeline are: ONIVYDE was approved by the U.S. FDA, Taiwan FDA, and EMA for patients with gemcitabine-treated metastatic pancreatic cancer; and PEP07. It generates the revenue from Sales of goods.

PharmaEngine Headlines

No Headlines